Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX1LSM
|
||||
| Drug Name |
(S)-1-((2S,4R)-4-(5-fluorobenzo[b]thiophen-2-yl)-2-methylpiperidin-1-yl)-3-(2-methyl-1H-indol-4-yloxy)propan-2-ol
|
||||
| Synonyms |
CHEMBL129238
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C26H29FN2O2S
|
||||
| Canonical SMILES |
C[C@H]1C[C@@H](CCN1C[C@H](O)COc2cccc3[nH]c(C)cc23)c4cc5cc(F)ccc5s4
|
||||
| InChI |
InChI=1S/C26H29FN2O2S/c1-16-10-22-23(28-16)4-3-5-24(22)31-15-21(30)14-29-9-8-18(11-17(29)2)26-13-19-12-20(27)6-7-25(19)32-26/h3-7,10,12-13,17-18,21,28,30H,8-9,11,14-15H2,1-2H3/t17-,18+,21-/m0/s1
|
||||
| InChIKey |
WEGCLSBGECOYJJ-UEXGIBASSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.